Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma

Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma

The present study clarified the prognosis of intermediate-stage hepatocellular carcinoma (HCC) patients who received lenvatinib (LEN) followed by transcatheter arterial chemoembolization (TACE) on demand. We retrospectively evaluated 88 intermediate-stage HCC patients who received LEN. The median ag...

Full description

Bibliographic Details
Main Authors: Seiichi Mawatari, Tsutomu Tamai, Kotaro Kumagai, Akiko Saisyoji, Kaori Muromachi, Ai Toyodome, Ohki Taniyama, Haruka Sakae, Sho Ijuin, Kazuaki Tabu, Kohei Oda, Yasunari Hiramine, Akihiro Moriuchi, Kazuhiro Sakurai, Shuji Kanmura, Akio Ido
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
hepatocellular carcinoma (HCC)
lenvatinib
TACE
intermediate stage
on demand
Online Access:https://www.mdpi.com/2072-6694/14/24/6139

Internet

https://www.mdpi.com/2072-6694/14/24/6139

Similar Items